Skip to main content
Premium Trial:

Request an Annual Quote

Montreal Heart Institute Named Roche Global Cardiometabolic Research Hub

NEW YORK (GenomeWeb News) – The Montreal Heart Institute today was designated by Roche as a global research hub for cardiometabolic research.

The partnership between Roche and the institute will focus on furthering basic scientific research into personalized healthcare for patients, they said.

"This alliance will provide a unique opportunity to drive translational and personalized medicine from molecular discovery up to testing new drugs in the area of cardiovascular and metabolic diseases," Jean-Claude Tardif, director of the MHI Research Center and Canada Research Chair in personalized and translational medicine, said in a statement.

David Kallend, Roche global clinical leader and pharma development group medical director, added that the institute's "focused research into new biomarkers to predict cardiovascular diseases and stratification of high-risk patients make MHI the ideal partner for Roche in cardiovascular research."

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.